501 related articles for article (PubMed ID: 14576974)
1. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP.
Koch HM; Bolt HM; Angerer J
Arch Toxicol; 2004 Mar; 78(3):123-30. PubMed ID: 14576974
[TBL] [Abstract][Full Text] [Related]
2. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
Koch HM; Bolt HM; Preuss R; Angerer J
Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144
[TBL] [Abstract][Full Text] [Related]
3. Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP).
Koch HM; Drexler H; Angerer J
Int J Hyg Environ Health; 2004 Jan; 207(1):15-22. PubMed ID: 14762970
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP.
Kessler W; Numtip W; Völkel W; Seckin E; Csanády GA; Pütz C; Klein D; Fromme H; Filser JG
Toxicol Appl Pharmacol; 2012 Oct; 264(2):284-91. PubMed ID: 22963843
[TBL] [Abstract][Full Text] [Related]
5. Inter-Day Variability of Metabolites of DEHP and DnBP in Human Urine-Comparability of the Results of Longitudinal Studies with a Cross-Sectional Study.
Hildenbrand S; Gabrio T; Volland G
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30901880
[TBL] [Abstract][Full Text] [Related]
6. Toxicokinetic relationship between di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in rats.
Koo HJ; Lee BM
J Toxicol Environ Health A; 2007 Mar; 70(5):383-7. PubMed ID: 17454563
[TBL] [Abstract][Full Text] [Related]
7. Intravenous exposure to di(2-ethylhexyl)phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation.
Koch HM; Bolt HM; Preuss R; Eckstein R; Weisbach V; Angerer J
Arch Toxicol; 2005 Dec; 79(12):689-93. PubMed ID: 16059725
[TBL] [Abstract][Full Text] [Related]
8. A simple pharmacokinetic model to characterize exposure of Americans to di-2-ethylhexyl phthalate.
Lorber M; Angerer J; Koch HM
J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):38-53. PubMed ID: 19127283
[TBL] [Abstract][Full Text] [Related]
9. DEHP metabolites in urine of children and DEHP in house dust.
Becker K; Seiwert M; Angerer J; Heger W; Koch HM; Nagorka R; Rosskamp E; Schlüter C; Seifert B; Ullrich D
Int J Hyg Environ Health; 2004 Oct; 207(5):409-17. PubMed ID: 15575555
[TBL] [Abstract][Full Text] [Related]
10. Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry.
Preuss R; Koch HM; Angerer J
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):269-80. PubMed ID: 15664359
[TBL] [Abstract][Full Text] [Related]
11. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results.
Koch HM; Preuss R; Angerer J
Int J Androl; 2006 Feb; 29(1):155-65; discussion 181-5. PubMed ID: 16466535
[TBL] [Abstract][Full Text] [Related]
12. Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine.
Koch HM; Rossbach B; Drexler H; Angerer J
Environ Res; 2003 Oct; 93(2):177-85. PubMed ID: 12963402
[TBL] [Abstract][Full Text] [Related]
13. Urinary di(2-ethylhexyl)phthalate (DEHP)--metabolites and male human markers of reproductive function.
Herr C; zur Nieden A; Koch HM; Schuppe HC; Fieber C; Angerer J; Eikmann T; Stilianakis NI
Int J Hyg Environ Health; 2009 Nov; 212(6):648-53. PubMed ID: 19733116
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the phthalate metabolites mono-2-ethylhexyl phthalate (MEHP) and mono-n-butyl phthalate (MnBP) in male subjects after a single oral dose.
Mittermeier A; Völkel W; Fromme H
Toxicol Lett; 2016 Jun; 252():22-8. PubMed ID: 27091076
[TBL] [Abstract][Full Text] [Related]
15. Trends of the internal phthalate exposure of young adults in Germany--follow-up of a retrospective human biomonitoring study.
Göen T; Dobler L; Koschorreck J; Müller J; Wiesmüller GA; Drexler H; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Dec; 215(1):36-45. PubMed ID: 21889907
[TBL] [Abstract][Full Text] [Related]
16. Daily intake of di(2-ethylhexyl)phthalate (DEHP) by German children -- A comparison of two estimation models based on urinary DEHP metabolite levels.
Wittassek M; Heger W; Koch HM; Becker K; Angerer J; Kolossa-Gehring M
Int J Hyg Environ Health; 2007 Jan; 210(1):35-42. PubMed ID: 17185035
[TBL] [Abstract][Full Text] [Related]
17. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate.
Kato K; Silva MJ; Reidy JA; Hurtz D; Malek NA; Needham LL; Nakazawa H; Barr DB; Calafat AM
Environ Health Perspect; 2004 Mar; 112(3):327-30. PubMed ID: 14998748
[TBL] [Abstract][Full Text] [Related]
18. Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors.
Koch HM; Angerer J; Drexler H; Eckstein R; Weisbach V
Int J Hyg Environ Health; 2005; 208(6):489-98. PubMed ID: 16325559
[TBL] [Abstract][Full Text] [Related]
19. Skin permeation and metabolism of di(2-ethylhexyl) phthalate (DEHP).
Hopf NB; Berthet A; Vernez D; Langard E; Spring P; Gaudin R
Toxicol Lett; 2014 Jan; 224(1):47-53. PubMed ID: 24140552
[TBL] [Abstract][Full Text] [Related]
20. Urinary and amniotic fluid levels of phthalate monoesters in rats after the oral administration of di(2-ethylhexyl) phthalate and di-n-butyl phthalate.
Calafat AM; Brock JW; Silva MJ; Gray LE; Reidy JA; Barr DB; Needham LL
Toxicology; 2006 Jan; 217(1):22-30. PubMed ID: 16171919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
